Shape-shifting fat cells fuel breast cancer growth

Updated on: January 15,2024

Shape-shifting fat cells fuel breast cancer growth

Updated on:January 15,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on: July 05,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on:July 05,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on: November 09,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on:November 09,2024

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Updated on: January 08,2024

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Updated on:January 08,2024

Prostate cancer diagnosis later for Kiwi men

by Anna Kellett,University of AucklandDr Nishi Karunasinghe. Credit: University of AucklandNew Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific an

Updated on: March 01,2024

Prostate cancer diagnosis later for Kiwi men

by Anna Kellett,University of AucklandDr Nishi Karunasinghe. Credit: University of AucklandNew Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific an

Updated on:March 01,2024

Researchers first to develop comprehensive models of 'seeds and soil' as a means to combat breast cancer metastasis

by Virginia Commonwealth UniversityFrom left to right: Mohammad Alzubi, Chuck Harrell, Ph.D., and Tia Turner. Credit: VCU Massey Cancer CenterScientists at VCU Massey Cancer Center have identifie

Updated on: June 06,2024

Researchers first to develop comprehensive models of 'seeds and soil' as a means to combat breast cancer metastasis

by Virginia Commonwealth UniversityFrom left to right: Mohammad Alzubi, Chuck Harrell, Ph.D., and Tia Turner. Credit: VCU Massey Cancer CenterScientists at VCU Massey Cancer Center have identifie

Updated on:June 06,2024

Study pinpoints what causes relapse after cancer immunotherapy

by Elaine Fuchs,Rockefeller UniversityKiller T cells surround a cancer cell. Credit: NIHHarnessing the body's immune system to fight off cancer, a tactic known as immunotherapy, has tremendo

Updated on: May 25,2024

Study pinpoints what causes relapse after cancer immunotherapy

by Elaine Fuchs,Rockefeller UniversityKiller T cells surround a cancer cell. Credit: NIHHarnessing the body's immune system to fight off cancer, a tactic known as immunotherapy, has tremendo

Updated on:May 25,2024

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on: March 27,2024

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

Updated on:March 27,2024

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food

Updated on: May 21,2024

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food

Updated on:May 21,2024

Study unveils molecular pathways followed by metastatic cancer cells

by Baylor College of MedicineCredit: Unsplash/CC0 Public DomainMetastasis, the process by which cancer cells leave the primary tumor and spread to other tissues to seed new cancerous growth, caus

Updated on: February 01,2024

Study unveils molecular pathways followed by metastatic cancer cells

by Baylor College of MedicineCredit: Unsplash/CC0 Public DomainMetastasis, the process by which cancer cells leave the primary tumor and spread to other tissues to seed new cancerous growth, caus

Updated on:February 01,2024

Researchers target commonly mutated or deleted gene in gynecological cancers

by Sbarro Health Research Organization (SHRO)FBXW7 isoforms and SCF-FBXW7 complex. (A) Three FBXW7 isoforms (α, β, and γ), which are structurally different only at their N-terminal region, while shari

Updated on: January 30,2024

Researchers target commonly mutated or deleted gene in gynecological cancers

by Sbarro Health Research Organization (SHRO)FBXW7 isoforms and SCF-FBXW7 complex. (A) Three FBXW7 isoforms (α, β, and γ), which are structurally different only at their N-terminal region, while shari

Updated on:January 30,2024

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on: April 01,2024

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on:April 01,2024